LAB Financials
Standard Biotools Inc - Financial statements & key metrics
Stock Price
$0.65
Market Cap
$317.12M
P/E Ratio
-1.3
EPS
$-0.38
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$174.43M
Gross Profit
-
Operating Income
-
Net Income
$-138.88M
EPS (Diluted)
$-0.52
Balance Sheet Highlights
Total Assets
$612.34M
Total Liabilities
$140.62M
Shareholders Equity
-
Cash & Equivalents
$166.73M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-143.45M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-29.4%
Net Margin
-75.6%
ROE
-33.3%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is LAB revenue?
LAB's most recent quarterly revenue was $174.43M. Annual revenue can be calculated by summing the four most recent quarters.
Is LAB profitable?
LAB reported a loss of $138.88M in the most recent quarter. The net profit margin is -75.6%.
What is LAB market cap?
LAB has a market capitalization of $317.12M, making it a small-cap stock.
Does LAB have debt?
View LAB's balance sheet for debt information.
What is LAB cash flow?
Cash flow data is available in the full financial statements.